Skip to content

Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea

Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07435493
Enrollment
64
Registered
2026-02-27
Start date
2026-11-30
Completion date
2026-12-30
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenotonsillectomy, Fentanyl, Obstructive Sleep Apnea (OSA), Opioid

Keywords

opioid, Fentanyl, obstructive sleep apnea, adenotonsillectomy

Brief summary

Emphasize that the usage of multimodal analgesia in managing perioperative pain in children with mild to moderate Obstructive Sleep Apnea undergoing adenotonsillectomy may achieve the same efficacy of fentanyl with less respiratory complications and less opioid-related side effects.

Detailed description

Obstructive Sleep Apnea in pediatrics is a sleep disorder characterized by repeated episodes of partial or complete upper airway obstruction during sleep, leading to disrupted breathing, poor sleep quality, and potential developmental and health issues. Since adeno-tonsillar hypertrophy and enlarged tonsils & adenoids are the most common causes of pediatric Obstructive Sleep Apnea ,thus adenotonsillectomy is the first-line surgical treatment and is one of the most common pediatric surgeries that has a high success rate in resolving Obstructive Sleep Apnea symptoms with cure rate up to 80%. Adenotonsillectomy is a common surgical procedure in pediatric patients and perioperative pain management with opioids is common and associated with side effects and risks. Consequently, analgesic strategies to reduce opioid utilization have been developed, because Obstructive Sleep Apnea patients are more sensitive to opioids. Fentanyl has demonstrated efficacy in pediatrics for acute pain management but still has the risk of opioids induced ventilatory impairment which is very common in children with obstructive sleep apnea due to altered volume of distribution and clearance. A multimodal analgesia approach, which combines various non-opioid medications (acetaminophen, non-steroidal anti-inflammatory drugs, dexamethasone and ketamine ) can effectively manage perioperative pain in children with mild to moderate Obstructive Sleep Apnea with (apnea hypoxia index \<or= 10) undergoing adenotonsillectomy, while minimizing the risks associated with opioid use. The purpose of this study is to emphasize that the usage of multimodal analgesia in managing perioperative pain in children with mild to moderate OSA undergoing adenotonsillectomy may achieve the same efficacy of fentanyl with less respiratory complications and less opioid-related side effects.

Interventions

DRUGGroup A: Fentanyl-Based Analgesia

Fentanyl-Based Analgesia will receive intraoperative fentanyl (1 μg/kg IV) with standard anesthetic care with postoperative rescue analgesia with acetaminophen (15 mg/kg) as needed

DRUGGroup B: Opioid-Free Multimodal Analgesia

Opioid-Free Multimodal Analgesia will receive preoperative acetaminophen (15 mg/kg) and ibuprofen (10 mg/kg), intraoperative ketamine (0.5 mg/kg IV) and dexamethasone (0.1 mg/kg IV) with postoperative rescue analgesia with acetaminophen as needed.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 5-10 years. * Diagnosed with mild to moderate Obstructive Sleep Apnea (apnea-hypoxia index 1-10). * Scheduled for elective adenotonsillectomy. * American Society of Anesthesiologists physical status I-II.

Exclusion criteria

* Severe Obstructive Sleep Apnea (apnea-hypoxia index \>10). * Known allergies to study medications. * Patient with predicted difficult air way (Mallampatti 3\&4). * History of opioid use or chronic pain syndromes. * Neurological or metabolic disorders affecting pain perception. * Parental refusal to consent.

Design outcomes

Primary

MeasureTime frameDescription
FLACC Scale (face, legs, activity, cry, consolability)at 0 hours, 2hours, and 6 hours postoperativelyIt grades pain from 0 to 10 by observing five categories-Face, Legs, Activity, Cry, and Consolability-with each item scored 0-2.

Secondary

MeasureTime frame
Time to oral intake6 hours postoperatively

Countries

Egypt

Contacts

CONTACTAnhar Falila, Assistant Lecturer
Anhar.fathy@med.asu.edu.eg01222176925

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026